Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01824290
What this trial is testing

Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Hypertension, Pulmonary
Eli Lilly and Company 35
Testing effectiveness (Phase 2)WithdrawnNCT03016468
What this trial is testing

Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics
Not applicableUnknownNCT01397110
What this trial is testing

Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects

Who this might be right for
Pulmonary Arterial HypertensionEisenmenger Syndrome
Heidelberg University 50
Not applicableStudy completedNCT03863990
What this trial is testing

Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs

Who this might be right for
Pulmonary Arterial Hypertension
Bayer 104
Not applicableNot Yet RecruitingNCT07356375
What this trial is testing

Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral Selexipag in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
University of Sao Paulo General Hospital 32
Large-scale testing (Phase 3)Looking for participantsNCT06274801
What this trial is testing

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

Who this might be right for
Pulmonary Arterial Hypertension
Gossamer Bio USA, Inc. 330
Early research (Phase 1)Looking for participantsNCT06872112
What this trial is testing

A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Joseph C. Wu 15
Testing effectiveness (Phase 2)Ended earlyNCT04125745
What this trial is testing

Oral CXA-10 in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Gladwin, Mark, MD 1
Large-scale testing (Phase 3)Study completedNCT03422328
What this trial is testing

A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.

Who this might be right for
Pulmonary Arterial HypertensionChronic Thromboembolic Pulmonary Hypertension
Actelion 151
Not applicableStudy completedNCT00609349
What this trial is testing

The Early Recognition of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Medical University of Graz 52
Early research (Phase 1)Study completedNCT04991155
What this trial is testing

Effect of Food on BIA 5-1058

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 57
Large-scale testing (Phase 3)Study completedNCT01106014
What this trial is testing

Selexipag (ACT-293987) in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 1,156
Testing effectiveness (Phase 2)Study completedNCT00990314
What this trial is testing

Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients

Who this might be right for
Pulmonary Arterial Hypertension
Lung Biotechnology PBC 31
Not applicableStudy completedNCT02028299
What this trial is testing

Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography

Who this might be right for
Pulmonary Arterial Hypertension
George Washington University 38
Large-scale testing (Phase 3)UnknownNCT01712997
What this trial is testing

Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients

Who this might be right for
Pulmonary Arterial Hypertension
Air Force Military Medical University, China 90
Large-scale testing (Phase 3)Study completedNCT01338415
What this trial is testing

FUTURE 3 Study Extension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 58
Very early researchUnknownNCT02023450
What this trial is testing

Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
The Third Xiangya Hospital of Central South University 20
Not applicableLooking for participantsNCT07149935
What this trial is testing

Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients

Who this might be right for
Pulmonary Hypertension
RenJi Hospital 104
Testing effectiveness (Phase 2)Study completedNCT03738150
What this trial is testing

Sotatercept for the Treatment of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 21
Large-scale testing (Phase 3)Study completedNCT02932410
What this trial is testing

Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 165
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation